Health and Fitness Health and Fitness
Fri, February 21, 2025
Thu, February 20, 2025

Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss


Published on 2025-02-20 13:03:11 - MSN
  Print publication without navigation

  • The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the world. Now, the pharma giant wants to reinvest its success with weight-loss meds into tackling some of the world's toughest health challenges.

Eli Lilly, a pharmaceutical company, is planning to leverage the substantial profits from its weight-loss drug, Zepbound, to fund research into treatments for Alzheimer's disease and hearing loss. The company has already seen significant success with Zepbound, which has not only helped patients lose weight but also shown potential in reducing the risk of heart disease. With the financial windfall from this drug, Eli Lilly aims to expand its research portfolio. Specifically, they are focusing on developing treatments for Alzheimer's, where they are testing a drug called donanemab, which has shown promise in slowing cognitive decline. Additionally, Eli Lilly is exploring treatments for hearing loss, an area with limited therapeutic options currently. This strategic move is part of Eli Lilly's broader goal to address major health challenges as the global population ages.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/other/eli-lilly-wants-to-use-its-weight-loss-drug-windfall-to-fight-alzheimer-s-and-hearing-loss/ar-AA1zsspW ]
Contributing Sources